High PD-L1 expression was observed in 25 of 43 patients (58%) with metastatic NPC, while it was observed only in 7 of 35 patients (20%) without metastasis (p = 0.001, Figure 2A). This evidence concerns the gene CD274 and nasopharyngeal carcinoma.